Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: maceng2 who wrote (175893)	8/7/2021 4:55:16 AM
From: TobagoJack	Read Replies (1) \| Respond to of 218232

Wonderful how the Boyz and Girlz can play well together and get something done thedailystar.net Scientists of India, China, Russia, Brazil come together for Covid-19 study Star Digital Report Fri Aug 6, 2021 12:59 PM Scientists from the world's four major economies, India, China, Russia and Brazil, have come together to carry out genomic sequencing of Covid-19 and studies on the epidemiology and mathematical modelling of the pandemic. This will help trace genetic mutations, re-combinations as well as distribution of the virus and also make projections about the future of its spread, reports our New Delhi correspondent quoting an official statement released today. A whole-genome sequencing is required for identification of genetic mutations and re-combinations of the virus while epidemiological studies can help assess its distribution. The mathematical modelling is required to assess its future spread. Keeping this in mind, a research plan has been made including the expertise of scientists and engineers from diverse backgrounds from the four countries to form a consortium under the banner of the four-nation trans-continental grouping called BRICS (Brazil, Russia, India, China and South Africa), states the release. Under this research project, India and Brazil will assess the distribution of SARS-CoV-2 in environmental samples through metagenome analysis for wastewater-based epidemiology surveillance while Chinese and Russian scientists will carry out the real-time PCR detection of SARS-CoV-2 in biological material (nasopharyngeal swabs) from patients with symptoms of respiratory diseases and investigate the genomic variability, comparative genomics and phylogenetic analysis. The genomic, metagenomic and epidemiological data from India, China, Russia and Brazil will be integrated to develop mathematical models for mutations analysis, population genetics, phylogenetic relationship, recombination analysis and risk evaluation to reveal the spread network and dynamics of the virus. The database developed by the different groups will also compare the distribution and survival of the virus in the different regions and establish the surveillance of the relevant early warning system.